AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anthony, T. U.
Right arrow Articles by Rubin, L. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anthony, T. U.
Right arrow Articles by Rubin, L. G.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 1999, p. 2074-2076, Vol. 43, No. 8
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Stability of Antibiotics Used for Antibiotic-Lock Treatment of Infections of Implantable Venous Devices (Ports)

Thiele Umali Anthony and Lorry G. Rubin*

Division of Infectious Diseases, Department of Pediatrics, Schneider Children's Hospital of Long Island Jewish Medical Center, the Long Island Campus for the Albert Einstein College of Medicine, New Hyde Park, New York 11040

Received 6 November 1998/Returned for modification 22 April 1999/Accepted 3 June 1999

Antibiotic-lock is a treatment for catheter-related bloodstream infections in which a solution containing heparin and an antibiotic dwells in the lumen of the catheter or port. We tested the stability of vancomycin, cefazolin, ticarcillin-clavulanic acid, ceftazidime, or ciprofloxacin combined with heparin after incubation in vitro at 25 or 37°C for intervals of up to 10 days by bioassay. All the antibiotic solutions except ceftazidime retained >= 90% activity at both 25 and 37°C. Thus, studies of antibiotic-heparin lock solutions with dwell times of up to 10 days are feasible.

* Corresponding author. Mailing address: Schneider Children's Hospital, 269-01 76th Ave., New Hyde Park, NY 11040. Phone: (718) 470-3480. Fax: (718) 470-0887. E-mail: lrubin{at}lij.edu.

Antimicrobial Agents and Chemotherapy, August 1999, p. 2074-2076, Vol. 43, No. 8
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 1999 by the American Society for Microbiology. All rights reserved.